Stocks in Play

RepliCel Life Sciences Inc.

09:52 AM EST - RepliCel Life Sciences Inc. : Has appointed a syndicate of agents co-led by Echelon Wealth Partners Inc. and Haywood Securities Inc., with participation from Clarus Securities Inc., to undertake a brokered private placement, on a commercially reasonable basis, of up to 1,600,000 units, at a price of $1.25 per Unit. RepliCel Life Sciences Inc. shares V.RP are trading down $0.25 at $1.45.